EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling the Relation of Parkinson's Disease and Metabolites: A Combined Analysis of Stool and Plasma Metabolites Based on Untargeted Metabolomics Technology

Sufang Liu iD, Qiang Zhao, Jie Tang, Xianhong Li, Juan Wang, Yuting Zhao, Zhengting Yang, Xin Pan, Rui Xiang, Jing Tian, Puqing Wang

CNS Neuroscience & Therapeutics · 2025-05 · 31 (5)

DOI: 10.1111/cns.70424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 16.05.2025. Verfasst von Sufang Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei, China. Hauptthemen laut MEDLINE: Parkinson Disease, Metabolomics, Feces. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hubei Province, Science and Technology Program of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Metabolomics technology has been widely utilized to uncover the action mechanisms of Parkinson's Disease (PD) and to identify PD‐related biomarkers. In this study, we compared plasma and fecal metabolite levels between PD patients and their healthy spouses (HS), aiming to identify the associations of differential metabolites with intestinal inflammation, intestinal barrier function, and clinical characteristics of PD.

Methods

Untargeted metabolomics techniques were used to characterize plasma and fecal metabolite profiles. We identified metabolites with elevated plasma levels in PD patients, while no significant differences were observed in fecal samples. Partial correlation analysis was employed to investigate the associations between these metabolites, markers of intestinal inflammation (calprotectin and lactoferrin), markers of intestinal permeability (α‐1‐antitrypsin and zonulin), and clinical characteristics of PD patients.

Results

The study identified ten metabolites that were significantly elevated in the plasma of PD patients compared to HS ( p < 0.05), while their fecal concentrations did not differ significantly. Correlation analysis revealed that elevated levels of differential metabolites in the plasma of PD patients were associated with increased intestinal permeability and inflammation. Furthermore, five metabolites, including 3,4‐Dihydroxyphenylglycol O‐sulfate and Propyl gallate, were linked to PD symptoms. Receiver Operating Characteristic (ROC) curves demonstrated that these metabolites could effectively distinguish between PD patients and HS, with an area under the curve (AUC) of 0.94, indicating excellent predictive performance.

Conclusions

This study identified significant metabolite alterations in PD patients and revealed their associations with intestinal barrier dysfunction and clinical characteristics of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMetabolomicsFecesHumansMaleFemaleMiddle AgedAgedBiomarkers

Stichwörter der Autor:innen

Parkinson's diseasebiomarkersintestinal inflammationintestinal permeabilityuntargeted metabolomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei, China.
  • Hubei Provincial Clinical Research Center for Parkinson's Disease, Xiangyang Key Laboratory of Movement Disorders, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei, China.

ORCID-Profile: Sufang Liu

Förderung

  • Natural Science Foundation of Hubei Province
  • Science and Technology Program of Hubei Province

Zitieren

APA

Liu, S., Zhao, Q., Tang, J., Li, X., Wang, J., Zhao, Y., Yang, Z., Pan, X., Xiang, R., Tian, J., & Wang, P. (2025). Unraveling the Relation of Parkinson's Disease and Metabolites: A Combined Analysis of Stool and Plasma Metabolites Based on Untargeted Metabolomics Technology. CNS Neuroscience & Therapeutics, 31(5). https://doi.org/10.1111/cns.70424

Vancouver

Liu S, Zhao Q, Tang J, Li X, Wang J, Zhao Y, et al. Unraveling the Relation of Parkinson's Disease and Metabolites: A Combined Analysis of Stool and Plasma Metabolites Based on Untargeted Metabolomics Technology. CNS Neuroscience & Therapeutics. 2025;31(5). doi:10.1111/cns.70424

BibTeX
@article{Liu2025,
  author = {Liu, Sufang and Zhao, Qiang and Tang, Jie and Li, Xianhong and Wang, Juan and Zhao, Yuting and Yang, Zhengting and Pan, Xin and Xiang, Rui and Tian, Jing and Wang, Puqing},
  title = {Unraveling the Relation of Parkinson's Disease and Metabolites: A Combined Analysis of Stool and Plasma Metabolites Based on Untargeted Metabolomics Technology},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  volume = {31},
  number = {5},
  doi = {10.1111/cns.70424}
}
Kostenlos starten →